SurvMicro: assessment of miRNA-based prognostic signatures for cancer clinical outcomes by multivariate survival analysis

UNLABELLED MicroRNAs (miRNAs) play a key role in post-transcriptional regulation of mRNA levels. Their function in cancer has been studied by high-throughput methods generating valuable sources of public information. Thus, miRNA signatures predicting cancer clinical outcomes are emerging. An important step to propose miRNA-based biomarkers before clinical validation is their evaluation in independent cohorts. Although it can be carried out using public data, such task is time-consuming and requires a specialized analysis. Therefore, to aid and simplify the evaluation of prognostic miRNA signatures in cancer, we developed SurvMicro, a free and easy-to-use web tool that assesses miRNA signatures from publicly available miRNA profiles using multivariate survival analysis. SurvMicro is composed of a wide and updated database of >40 cohorts in different tissues and a web tool where survival analysis can be done in minutes. We presented evaluations to portray the straightforward functionality of SurvMicro in liver and lung cancer. To our knowledge, SurvMicro is the only bioinformatic tool that aids the evaluation of multivariate prognostic miRNA signatures in cancer. AVAILABILITY AND IMPLEMENTATION SurvMicro and its tutorial are freely available at http://bioinformatica.mty.itesm.mx/SurvMicro.

[1]  F. Slack,et al.  Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.

[2]  R. Schiff,et al.  Systemic mirnas as potential biomarkers for malignancy , 2012, International journal of cancer.

[3]  Stijn van Dongen,et al.  miRBase: microRNA sequences, targets and gene nomenclature , 2005, Nucleic Acids Res..

[4]  A. Dreher.  Modeling Survival Data Extending The Cox Model , 2016 .

[5]  B. Reinhart,et al.  The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans , 2000, Nature.

[6]  Ming Shi,et al.  Clinical Significance and Prognostic Value of microRNA Expression Signatures in Hepatocellular Carcinoma , 2013, Clinical Cancer Research.

[7]  Gang Feng,et al.  Disease Ontology: a backbone for disease semantic integration , 2011, Nucleic Acids Res..

[8]  Chirayu Pankaj Goswami,et al.  PROGmiR: a tool for identifying prognostic miRNA biomarkers in multiple cancers using publicly available data , 2012, Journal of Clinical Bioinformatics.

[9]  Yidong Chen,et al.  GEOmetadb: powerful alternative search engine for the Gene Expression Omnibus , 2008, Bioinform..

[10]  C. Croce,et al.  MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.

[11]  P. Grambsch,et al.  A Package for Survival Analysis in S , 1994 .

[12]  Xiaoguang Fang,et al.  MicroRNAs: novel regulators in the hallmarks of human cancer. , 2009, Cancer letters.

[13]  D. Beer,et al.  MicroRNA classifiers for predicting prognosis of squamous cell lung cancer. , 2009, Cancer research.

[14]  R. Knight,et al.  MIRUMIR: an online tool to test microRNAs as biomarkers to predict survival in cancer using multiple clinical data sets , 2012, Cell Death and Differentiation.

[15]  Scott E Kern,et al.  Why your new cancer biomarker may never work: recurrent patterns and remarkable diversity in biomarker failures. , 2012, Cancer research.

[16]  Sung-Liang Yu,et al.  MicroRNA signature predicts survival and relapse in lung cancer. , 2008, Cancer cell.